LONDON–(BUSINESS WIRE)–Ixaka Ltd, an integrated cell and gene therapy company focused on boosting the natural power of the body to cure disease, today announces the appointment of Dr Karen Miller as Chief Scientific Officer. Karen joins Ixaka bringing more than 30 years of experience in the biotech and pharma industry, leading drug discovery, preclinical and … [Read more…]
TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#Artilysin–The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record of more than 30 years experiences in relevant commercial areas. As Director of Sales & Marketing at AMICOGEN, a leading manufacturer … [Read more…]
The Board of Directors unanimously recommends that shareholders vote FOR the Arrangement Not for distribution to U.S. news wire services or for dissemination in the U.S. TORONTO–(BUSINESS WIRE)–LifeWorks Inc. (TSX: LWRK, “LifeWorks” or the “Company”), today announced that it has filed and is in the process of mailing the Management Information Circular and related materials … [Read more…]
BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2022 results on Tuesday, August 9, 2022. The Company will host a conference call on Tuesday, August 9, 2022, at 10:00 a.m. ET to discuss these results. To access the call, … [Read more…]
TORONTO–(BUSINESS WIRE)–The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is excited to announce the expansion of Canada’s Early Adopter Health Network (EAHN™) and the launch of its new Women in Health Initiative (WiHI) to train women to further ensure their participation and career success in the … [Read more…]
Experienced Biotech Leader and Capital Markets Professional Elevated to Chief Financial Officer from Chief Business Officer Role Appointment Effective July 11, 2022 WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it has appointed Micah Zajic, as the company’s Chief Financial Officer, … [Read more…]
BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials. Through this collaboration, oncology clinical trials managed by Labcorp Drug … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced the appointment of Nick Mordwinkin, Pharm.D., Ph.D., as Chief Business Officer. Dr. Mordwinkin will be key to the next stage of Kezar’s growth and will be responsible for shaping … [Read more…]
GSK begins shipping FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT PHILADELPHIA–(BUSINESS WIRE)–#Flu–GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2022-23 season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for … [Read more…]
HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE:OHI) announced today that it is scheduled to release its earnings results for the quarter ended June 30, 2022, on Monday, August 1, 2022, after market close. In conjunction with its release, Omega will be conducting a conference call on Tuesday, August 2, 2022, at 10 a.m. Eastern … [Read more…]
